Rating Change
Roth Capital reiterated its Buy rating on 908 Devices Inc. (NASDAQ:MASS) on August 12, 2026.
Roth Capital reiterated its Buy rating on 908 Devices Inc. (NASDAQ:MASS) on August 12, 2026.

At publication ·
908 Devices Inc. (NASDAQ:MASS) · reiterate
At a glance
Roth Capital reiterated its Buy rating on 908 Devices Inc. (NASDAQ:MASS) on August 12, 2026.
908 Devices Inc. operates in the Healthcare sector. The stock currently trades at $10.02 with a market capitalization of $232.0M. The stock has gained 55.9% over the past 52 weeks.
Analyst coverage from Roth Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for 908 Devices Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 12, 2026 | Roth Capital | Buy | N/A |
| Aug 12, 2026 | Stifel | Buy | N/A |
| Jul 29, 2026 | Roth Capital | Buy | N/A |
| Aug 05, 2025 | Leerink Partners | Outperform | N/A |
| Jan 15, 2025 | Stephens & Co. | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View MASS Stock Page
A rating of Buy from Roth Capital reflects the analyst's outlook on 908 Devices Inc. (NASDAQ:MASS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MASS forecast page.
Current market data
NASDAQ · MASS
$9.35
Up: +$0.17 · +1.82%
Live quote updated
Keep reading